Analọg "Charter": reviews na photos. The Russian Ẹkot "Hart": reviews nke Cardiology

Ọbara mgbali - otiti nke ụwa nke oge a bi. A ọnụ ọgụgụ nke oghom mpụga ihe, ogbenye na gburugburu ebe obibi, mgbe nile nchegbu, n'ahụ, ọ na oge ufodu ike preconditions maka mmepe nke ọrịa obi na ọdịdị a egwu ọrịa.

Modern Pharmacy agbalịsi ike dị otú ahụ ọgwụ ọjọọ eme ihe, nke, ma ọ bụrụ na adịghị agwọ onye si ọbara mgbali kpamkpam, mgbe ahụ, ọ dịkarịa ala, ga-gị na ọbara mgbali n'okpuru akara, si otú n'ibelata ihe ize ndụ nke myocardial infarction na ọrịa strok.

Ugbu a, ndị elu ina nke na-eji ọkụ na-eji ndị a antihypertensive ọgwụ ndị dị otú ahụ dị ka "Hart", analogs nke a ọgwụ, nke mepụtara a otutu.

"Charter"

Producer nke "n'akwụkwọ iwu" nke ọgwụ bụ a Hungarian ụlọ ọrụ EGIS Pharmaceuticals PLC. Imu nwere atọ iche a ọgwụ, "Hart," "Hart D" na "Hart Amlo."

Isi nọ n'ọrụ akụrụngwa nke "Charter" bụ a umi ramipril. The isi na-egosi na iji jiri a ọgwụ na ụmụ mmadụ bụ ọnụnọ nke ọrịa ndị dị ka ọbara mgbali elu, ọrịa nephropathy, akụrụ ọrịa, asị ibe yi-adịghị ala ala. Ke adianade do, "Charter" ntuziaka maka ojiji (yiri ọtụtụ mgbe ga-emekwa ka a mmetụta dị mma) na-atụ aro iji belata likelihood nke myocardial infarction, "gbasara obi ọnwụ", ọrịa strok na ndị mmadụ na ịrịa ọrịa obi (ịrịa ọrịa obi). Ọzọkwa, omume nke n'ịhọpụta "n'akwụkwọ iwu" maka ndị na-ata ahụhụ gbasara obi insufficiency ya-adịghị ala ala na ogbo na mepụtara mgbe onye ọrịa nwere nnukwu myocardial infarction (a mkpa iji itinye "Charter" - a ufọk ufene hemodynamic parameters).

The agwọ ọrịa "Hart D" (dị analogs emetụta ọ bụla) mejupụtara abụọ ifịk ifịk mmiri - Ramipril na hydrochlorothiazide. The mbụ akụrụngwa lowers ọbara mgbali elu, si otú mbenata ibu na obi. The abụọ umi bụ a mamịrị, na-akpali akpali usoro nke wepụ nnu na mmiri site akụrụ, na otu dị ka ramipril ala ọbara mgbali. N'ihi ya, "Hart D" kenyere maka ọgwụgwọ nke ọbara mgbali ebe gosiri mgbagwoju ọgwụgwọ na Ace inhibitors, diuretics na mmadụ.

Drug antihypertensive ọgwụ "Hart Amlo" (yiri na mejupụtara na mmetụta nke oge a na-ere ọgwụ dị) nwere isi ihe abụọ na bekee - ramipril na amlodipine. Nzube nke a ọgwụ na-eme maka ọgwụgwọ nke ọbara mgbali na ọrịa ndị na-nwere a yiri ramipril na amlodipine nwere nti mmetụta ma n'otu n'otu na Nchikota.

"Ramipril-C3"

Drug "Ramipril-C3" - bụ ihe analogue nke "Hart" na Russia. "Northern Star" dị na Moscow now. Isi nọ n'ọrụ mgwa - ramipril. Inyeaka protrude magnesium stearate na lactose monohydrate.

Ọgwụ kenyere ndị dị otú ahụ na diagnoses dị ka ọbara mgbali elu, gbasara obi insufficiency (-adịghị ala ala ụdị na ịzụlite mgbe nnukwu myocardial infarction).

Na ọrịa ndị dị mkpa maka oru "Ramiplila-C3" - anụ hemodynamics. Ọ bụkwa ihe na-egosi na-analogue mbadamba "n'akwụkwọ iwu" bụ ọnụnọ ke ndidi nke-arịa ọrịa shuga na-abụghị ọrịa nephropathy. Na-atụ anya ihe ọma n'ihi kenyere "Ramipril-C3" ndị mmadụ mgbe ahụ n'ihi transluminal akwara angioplasty na akwara akwara uzo grafting (ma ọ bụrụ na clinically mụ ndidi eguzo).

Ka contraindications maka anata agwọ ọrịa ịrụ onye hypersensitivity ka isi ma ọ bụ nke abụọ mmiri nke nkwadebe, a akụkọ ihe mere eme nke ozi mbụ bufere angioneurotic edema, iwe na ọgwụ ọjọọ, Ace inhibitors. Contraindicated "Ramipril -C3" ọrịa n'okpuru afọ 18, n'ihi na enweghị ihe ọmụma banyere ya na nchekwa na irè.

"Dilaprel"

Antihypertensive ọgwụ "Dilaprel" na-dị ka ndị Russian Ẹkot "Hart" na-emepụta ọgwụ ahịa. Isi nọ n'ọrụ mgwa - ramipril. Inyeaka protrude calcium stearate na colloidal sịlịkọn dioxide.

Egosi maka ojiji nke ọgwụ: ọnụnọ ke ọrịa nke ọrịa ndị dị ka oké mkpa ọbara mgbali elu, impairment nke gbasara obi ọrụ na-adịghị ala ala na ogbo (na Nchikota na ndị ọzọ ọgwụ ọjọọ eme ihe, karịsịa na a mamịrị).

Prescribing omume nephropathy (ọrịa, na-abụghị ọrịa), tinyere mgbe jikọtara na proteinuria, ọbara mgbali. Achọ ịnabata "Dilaprel" na ndị ahụ, mgbe mgbe a ụbọchị ole na ole (2-9 ụbọchị) mgbe nnukwu myocardial infarction mepụtara gbasara obi ọdịda.

Arụpụta ezi na-e nyere ọgwụ ndị ọrịa onye steeti ahụ ike e ji elu obi n'ihe ize ndụ (mberede mmalite nke nnukwu myocardial infarction, ọrịa strok).

Ndọkwasi wee ghara aha-enweta ndị na analọg ( "Hart" e ji n'ụzọ otu contraindications), na-ewere a akụkọ ihe mere eme nke angioneurotic edema, hemodynamically ịrịba gbasara akụrụ akwara stenosis, stenosis nke aortic ma ọ bụ mitral valvụ, hypotension (ala ọbara mgbali), ọdịda gbasara akụrụ ọrụ na mkpa dialysis. ghara ịdị irè n'ikuku "Dilaprela" ọrịa na-ezughi oke gbasara obi ọrụ hronichesoy ụdị DEKOM ogbo ensatsii na n'iru nephropathy. Na nnukwu-adọ nke a nkụchi obi ọgwụ na-adịghị kenyere ejighị n'aka rịaworo, akpa ume na obi, na oké njọ ventricular gbasara obi arrhythmias.

"Vazolong"

Nke a analọg ( "Hart" nwere otu isi ọrụ akụrụngwa - ramipril) nwere ndị na-esonụ na-egosi maka: ọbara mgbali (ọbara, refractory, oké njọ, renovascular), nephropathy (ọrịa na-emepe emepe na ndabere nke-adịghị ala ala asị ibe gbasara akụrụ ọrịa).

Ọ na-akpa a cardioprotective mmetụta na budata belata platelet aggregation. The agwọ ọrịa mma na uche nke anụ ahụ na insulin. Hypotensive mmetụta na e nwere otu na ọkara awa mgbe na-anata agwọ ọrịa, na kacha mmetụta na-enweta mgbe 5-9 awa ikpughe oge - ruo awa 24.

Nke isi contraindication maka ojiji nke a ọgwụ nwere ike mata hypersensitivity ka mmiri (isi na inyeaka) na agwọ ọrịa ma ọ bụ ka ọ bụla ọzọ Ace inhibitors, ọnụnọ nke a akụkọ ihe mere eme ihe ọmụma banyere mbụ kwagara angioneurotic edema, iwe na ọgwụgwọ na Ace inhibitors.

Mgbe afọ ime a na-contraindicated na-a usọbọ, nakwa dị ka "Charter". Ntuziaka maka ojiji, ezigbo (analogues nke "Charter", nwere a akụkụ nke ramipril, ike-kenyere ụmụ nwaanyị dị ime), ndị ọkachamara ahụ ike nwere ike ikwu na a tupu ọgwụgwọ iji hụ enweghị ime. Ọ bụrụ na onye ọrịa na-aghọ ime n'oge ọgwụ ga-ebulikwa ozugbo ọgwụ ọjọọ ramipril na họrọ ọ bụla ọzọ usoro ọgwụgwọ.

"Amprilan"

Na ihe dị otú ahụ Ace inhibitor, dị ka "Amprilan", na-analogous ka "n'akwụkwọ iwu", ma na mejupụtara na na mmetụta. Isi nọ n'ọrụ mgwa nke Medicine - ramipril. Na a hotara na mmiri protrude sodium bicarbonate, lactose monohydrate, croscarmellose sodium, starch.

Egosi maka ojiji nke ọgwụ n'ozuzu, ọ fọrọ nke nta yiri ka na mbụ kọwara "Vazolongu", "Dilaprelu" ramipril-C3 ": ọbara mgbali elu, ala ala obi odida eme, nephropathy, mbelata verooyatnosti mmepe nke obi daa ọrịa.

Enumeration nke contraindications maka ojiji nke a ọgwụ bụ nnọọ ọtụtụ. "Amprilan" o siri kenyere ọrịa na-ata ahụhụ site na akwa ọrịa ndị dị ka abụọ-kwadoro gbasara akụrụ akwara stenosis na a hemodynamically ịrịba stenosis nke akwara ndị gara na-etolite a kpọchiri akụrụ, gbasara akụrụ insufficiency eme, ọnọdụ mgbe akụrụ transplantation na dialysis. The ọgwụ na-adịghị ekwe itinye ọrịa na ndị na-esonụ nsogbu obi: aortic na / ma ọ bụ mitral stenosis, ala ala gbasara obi ọdịda (decompensation ogbo), okpo cardiomyopathy na ọbara mgbali.

Anakwere dose ọgwụ na ndị inyom n'oge ime na ara-udia a nwa. Contraindication bụ n'okpuru afọ 18 afọ.

"Ramikardiya"

Drug analogues "n'akwụkwọ iwu" bụ ugbu a uko ezu jupụta na-emepụta ọgwụ ahịa. Ọzọ maara nke ọma analogue - "Ramikardiya". Egosi na contraindications ọgwụ ndị fọrọ nke nta yiri ka na mbụ tụlere "Amprilanom".

Tupu ịmalite ọgwụgwọ na a ọgwụ ọkachamara ike ịkwado inyocha ala nke akụrụ, n'ihi na dabere na ọnọdụ nke ndị a ozu họrọ onye dose maka ọgwụgwọ (ma ọ bụ ọgwụ o ajụ). N'oge ọgwụgwọ, ngwá ọrụ a bụ fọrọ nke nta yiri ka agwọ ọrịa "n'akwụkwọ iwu", ntuziaka maka ojiji (analogues, fọrọ nke nta niile nwere ike ime ka oké njọ ojoo akụrụ) na-atụ aro na-achịkwa ala nke urinary usoro, ọbara electrolyte mejupụtara, ọnụ ọgụgụ nke akụrụ enzymes na elu ọbara picture.

Ndị ọrịa bụ onye a ọmụmụ mpe, sodium, tupu ị malite na-ewere "Ramikardiyu", ọ dị mkpa iji wepu niile mmiri na electrolyte abnormalities. N'oge ọgwụgwọ na a ọgwụ adịghị anakwere omume dialysis iji membranes nke polyacrylonitrile, n'ihi na e nwere ihe ize ndụ nke anaphylactic Jeremaya mere.

"Ramigamma"

Nile analogues "Hart" na Russia. Ọzọ ndị dị otú ahụ ọgwụ ọjọọ a na-akpọ "Ramigamma". Isi nọ n'ọrụ mgwa - ramipril. Egosi na contraindications ndị yiri ndị nke na-ji n'elu kọwara ọgwụ ọjọọ. Agwọ na a gị n'ụlọnga ga-n'okpuru nlekọta nke ịga dọkịta.

Mgbe na-ewere nke mbụ dose of "Ramigammy", ma ọ bụ dịkwuo onunu ogwu a ndidi na-ewere diuretics, na-esote 8:00 dị ka mgbe o kwere omume dị mkpa tụọ ọbara mgbali. Nke a dị mkpa iji gbochie na-achịkwaghị achịkwa na ngwa ngwa hypotensive mmeghachi omume (dobe na ọbara mgbali). Nti-achọ ọrịa na-ata ahụhụ site na akwa ọrịa akụrụ na obi usoro.

N'oge ọgwụgwọ ọ dị mkpa ịchịkwa larịị nke mkpụrụ ndụ ọbara ọcha, ka ọ bụghị uche a oge nke leucopenia.

"Hart" analogs nke ọgwụ (gụnyere "Remigammu") ekwesịghị ndinọ ka ọrịa ndị na-na a nyere desensitizing omume (maka mbenata nfụkasị Jeremaya ka ọtịta ahụhụ). Concurrent Ace inhibitors na sensitizing mmadụ nwere ike ime ka mmepe nke oké ike,-eyi ndụ egwu anaphylactic mmeghachi omume ahu (akụkụ okuku ume na ọdịda, a dobe na ọbara mgbali, vomiting, wdg)

"Kardipril"

Ebinta otu pụtara maara nke ọma ọgwụ - ihe analogue nke "Hart" - "Kardipril". Active akụrụngwa - ramipril. Isi na-egosi maka ojiji nke ọgwụ - ọbara mgbali elu, congestive obi ọdịda (dị ka a akụrụngwa nke Nchikota ọgwụ), nephropathy (ya mbụ ogbo nakwa), gbasara obi insufficiency mgbe myocardial infarction.

Contraindications iji "Kardiprila" nnọọ ọtụtụ. Ọgwụ na-ekwesịghị kenyere ịnabata ọnụnọ nke gbasara akụrụ na imeju na ọdịda, systemic lupus erythematosus, gbasara akụrụ akwara stenosis, na hyperkalemia na hyponatremia, mmegbu nke ụmị ọkpụkpụ hematopoiesis. Ekwela idepụta ọgwụ n'oge ime, lactation na ọrịa n'okpuru afọ 18.

Na ihe ovadozu nke "Kardiprilom" nwere ike ịzụlite oké hypotension (dobe na ọbara mgbali), akụrụ odida, oké electrolyte abnormalities, ujo. Iwepụ mmetụta dị mkpa na-ebu na-aga n'ihu nlekota na na-elu-support nkiti ọrụ. Ọ bụrụ na a siri ike mgbali tụlee nwere ike ndinọ ọzọ ego nke sodium na oke mmiri. Hemodialysis ọ bụla dị ịrịba mmetụta ga-enye.

"Tritatse"

Gịnị ọzọ dị ndị analogue nke "Hart"? Ọzọ mara na ọtụtụ ebe ada ọgwụ ọrịa - "Tritatse". The ọgwụ dị na Germany na France. Isi nọ n'ọrụ mgwa - ramipril. Egosi maka ngwa, dị ka, Otú ọ dị, na contraindications dị yiri na niile na mbụ kọwara onunu ogwu pụtara Ace-inhibitors. Ọgwụgwọ na "Tritatse" emekarị na-ewe a ogologo oge, nke na nke ọ bụla kpebisiri ike site ịga dibịa.

Tupu ị malite ọgwụgwọ na a ọgwụ, ọ dị mkpa iji nyochaa na-anọghị nke na ọnọdụ ndị dị otú ahụ dị ka hyponatremia na hypovolemia. Na omume nke onye ọrịa na mbụ natara ọgwụ ọ bụla, diuretics, ha nwere na-ịkagbu ma ọ bụ ọ dịghị ihe ọzọ belata ha onunu ogwu nke 2-3 ụbọchị tupu mmalite nke ọgwụgwọ na iji "Tritatse".

Mgbe mbụ dose ma ọ bụ na-abawanye diuretics n'ụlọ ọgwụ ga-abụrụ-enye ịkpachara anya nlekota ọrịa ọ dịkarịa ala 8 awa. Nke a dị mkpa iji na-eme ihe kwesịrị ekwesị na kwa ngwa ngwa ọdịda ọbara mgbali.

Ọ bụrụ na onye ọrịa nwere obi bara ma ọ bụ ịza aza iche nke ọbara mgbali elu, ọrịa na "Tritatse" na-ekwe ka na-amalite na na a ọgwụ.

N'oge nile nke ọgwụgwọ na a ọgwụ ga-nyochaa gbasara akụrụ ọrụ, larịị nke ịta nke electrolytes, ọbara (haemoglobin, platelet ọnụ, leucocytes, erythrocytes, leukocyte usoro).

Expert uche na Ace

Olee banyere ihe ọ bụla dị oké njọ ọgwụ ngwaahịa nke ọ bụ ike na-agụnye "n'akwụkwọ iwu" na ya kacha mma analogues reviews cardiologist, dọkịta nke ọ bụla ọzọ iche iche ma ọ bụ onye ọrịa nwere ike ịhapụ ma nke oma ma na-ezighị ezi ntụziaka.

Kasị ọrịa na-akọwa onwe ya "Hart" na ọtụtụ nke ya ọgbọ dị ka a nnọọ ngwa ngwa-eme ọgwụ ọjọọ eme ihe, irè ọbụna na nnọọ ọbara mgbali elu. Na oge nke ikpughe na ọgwụ ọjọọ nke otu a na-esịmde 24 awa. Ọ bụ ezie na ndị ahịa nke ngwaahịa ndị a ịdị iche iche nke ukwuu, na ọ bụghị ihe niile ọgwụ ọjọọ eme ihe dị ka a dịgasị iche iche nke na-eji ọkụ.

E nwere, Otú ọ dị, na-ezighị ezi echiche banyere ọgwụ "Hart". Analogs reviews ọrịa nwekwara mgbe ụfọdụ na-akọwa na-ezighị ezi n'akụkụ. Ihe kpatara ya bụ na ndị a niile ịgba akwụkwọ nwere ike ime ka mmepe nke a dum ụyọkọ nke oghom ihe, ụfọdụ n'ime ndị na nnọọ arọ. Na nke a nke, ọgwụ ọkachamara na-eguzo n'ubi, akpọnwụwo ha ọrịa. Ọ bụ ezie na ihe ka n'ọnụ ọgụgụ nke ndị ọkachamara ahụ ike ikwere na ihe ọgwụ ọjọọ zọpụta ọtụtụ narị ndụ, na ha dị nnọọ mkpa maka ndị mmadụ. Ndị isi ihe abụghị ekenye onwe gị a larịị onwe-ọgwụ, na nditịm rube na nkwanye nke ịga dibịa.